Case Control Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 106409
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.106409
Table 4 Prevalence of advanced colorectal neoplasia according to scores and subgroups in the derivation cohort
Score
Proportion of individuals with ACN
95%CI
Subgroups
Proportion of individuals with ACN
95%CI
02.5% (13/530)1.3–4.2Low-risk group (0–2)3.3% (63/1938)2.4-4.0
12.6% (19/730)1.6–4.0
24.6% (31/678)3.1–6.4
37.3% (69/944)5.7–9.2Moderate-risk group (3–4)9.3% (185/1983)8.3-10.9
411.2% (116/1039)9.3–13.2
517.4% (84/482)14.1–21.1High-risk group (5–7)18.5% (124/671)15.6-21.6
620.6% (35/170)14.8–27.5
726.3% (5/19)9.1–51.2
Total8.1% (372/4592)7.3–8.9